IFN-γinterferon-gammabreast cancerimmunotherapy
…ch as LPS, or to bacteria in combination with interferon-gamma (IFN-γ).Results Based on the results obtained by fluorescent microscop…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 3,661–3,720 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
CZP1Ca/VitD1Candidalysin1Cannabis oil1Cannabixir® Medium Flos1Capivasertib plus fulvestrant1Ccl41Certepetide1Chiglitazar1Chloroaurate1Chocolate balloon catheter1Claude 3.7 Sonnet1Colovac1Compound 9911Cp1Cp_vanco1Cy1Cypermethrin1D&A1DEX-implant1DFX1DKK11DLM1DMM1DNAJ-PKAc1DON1DOR/3TC1DOR/3TC/TDF1DPI-44521DPP4i/GLP1RA1DS-73001DTG-2DR1DV-101Dato-dx1DeepSeek1Delta-24-RGDOX1Dickkopf-11Diclofenac-sodium1Dicloxacillin1Doxil1Durva1EHL FIX1EMONO1EMPA-treated1EQ-5D-5L1EQ-5D-Y-5L1ESK21EST1EZ-Blocker1Enalapril Krka1Epimax1ExoSeal1FABP41FE-11FLT3L-cDC11FP1FeNO-guided1FeNOLow1Fentanyl-xylazine1Fissios App1
Articles mentioning drugs
10,506 articles · page 566 of 876mammalian target of rapamycinbreast cancer
…f phosphatidylinositol-3-kinase (PI3K), protein kinase B (AKT), mammalian target of rapamycin (mTOR), forkhead box O (FOXO), mouse double minute 2 homolog (M…
LRK-4189LRK-4189-mediatedCRO
… and effectively targeted in vivo using a bifunctional degrader.LRK-4189 is currently in IND-enabling studies and will enter clinical tr…
PPmGenUniversity of Houstongastric cancerNational Institutes of HealthPIK3CA-associated breast cancerlung cancertriple-negative breast cancer
…n-HLA was predicted with TL-MHC17 and CrossDome.18 We developed PPmGen to generate APLs with single and double-point mutations for eac…
Ova257-264 SIINFEKLgp100/pmel 17Weill Cornell Medical CollegeimmunotherapyImmunogenic tumorslung adenocarcinomasJ Exp Med
…d for 48 hours with plate-bound antibodies or native or APLs of Ova257-264 SIINFEKL were phenotyped by flow cytometryAbstract 1296 Figure 2Principa…
pembrolizumabAmerican Italian Cancer Foundationnon-small cell lung cancerALK + lymphoma
…d neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, p…
86.6%
anti-CTLA4checkpoint inhibitorsmelanomaThe Cancer Genome AtlasGene Expression Omnibus
…ssociated with favorable outcomes only in patients treated with anti-CTLA4 (p<0.05). ScRNA analysis revealed elevated expression of NLRC5 …
immune checkpoint inhibitorICISamsung Medical CenterSeoul National University HospitalDiscovery Life Sciencesimmunotherapy
…tational Burden (TMB) has emerged as a predictive biomarker for immune checkpoint inhibitor (ICI) response across multiple cancer types. However, current c…
phorbol 12-myristate 13-acetateionomycinT cell-targeted immunotherapiescancer immunotherapies
…unctionality, NFAT-luciferase T cell lines were stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin, while NF-κB-luciferase myeloid lines were …
TG4050piplelinesolid tumorsbreast cancerNational Whole-Genome Project in JapanAMED
… A, e t al. Randomized phase I trial of adjuvant individualized TG4050 vaccine in patients with locally advanced resected HPV-negative…
pembrolizumabnivolumabresectable non-small-cell lung cancerresectable non-small cell lung cancerresectable lung cancerN Engl J MedNSCLCNSCLCpCRNeoadjuvant/perioperative chemoimmunotherapylung cancer
…berman M, Kato T, Tsuboi M, Lee SH, Gao S, et al. Perioperative pembrolizumab for early-stage non-small-cell lung cancer. N Engl J Med. 2023 …
BTN3A1 antibodyBristol Myers Squibb
…cell treatment either alone or in combination with an agonistic BTN3A1 antibody at a concentration that achieved 20–40% growth inhibition relat…